Viva Medical, UAB - financials and debts

Company age: 14 y. 2 mo.

Update

Viva Medical - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 120,758 296,814 599,333 1,019,637 590,581 904,290 1,028,918 895,067
Profit before tax 28,838 13,773 52,741 117,209 - - - -
Net profit 27,387 12,911 43,906 101,767 13,458 2,639 51,847 20,120
Equity 29,140 18,051 51,958 113,725 67,183 69,830 121,677 141,797
Liabilities 35,800 56,633 102,268 77,483 150,650 257,370 97,039 143,972
Non-current assets 20,587 17,905 25,768 42,746 14,601 8,420 12,505 46,502
Current assets 44,010 56,631 128,196 148,162 203,061 316,282 196,036 236,527
Total assets 64,597 74,536 153,964 190,908 217,662 324,702 208,541 283,029
Taxes paid
STI taxes - - - - - 91,407 137,920 123,210
Social insurance contributions - - - - - 24,421 17,630 13,743
Financial indicators
Revenue change y/y - +145.8% +101.9% +70.1% -42.1% +53.1% +13.8% -13.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 42.4% 17.3% 28.5% 53.3% 6.2% 0.8% 24.9% 7.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 94.0% 71.5% 84.5% 89.5% 20.0% 3.8% 42.6% 14.2%
Profit margin Net profit margin. Shows the overall profitability of the company. 22.7% 4.3% 7.3% 10.0% 2.3% 0.3% 5.0% 2.2%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 23.9% 4.6% 8.8% 11.5% - - - -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.2 3.1 2.0 0.7 2.2 3.7 0.8 1.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 120,758 82,833 143,839 210,961 120,117 208,684 287,143 261,968

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Viva Medical - Social security debts

From To Debt, €
2023-11-23 2023-12-06 1.04
2022-01-18 2022-01-19 1089.96
2021-12-16 2021-12-22 2.89
2021-11-30 2021-12-02 2.89

Viva Medical - VMI tax arrears

From To Overdue, €
2026-05-26 2026-05-26 4.24
2026-05-01 2026-05-25 4.38
2026-03-19 2026-03-20 0.44
2025-12-03 2025-12-12 0.36
2025-11-27 2025-12-02 0.0
2025-11-25 2025-11-26 0.0
2025-11-24 2025-11-24 0.0
2025-11-21 2025-11-23 0.0
2025-11-20 2025-11-20 0.0
2025-11-18 2025-11-19 0.0
2025-11-14 2025-11-17 0.0
2025-11-12 2025-11-13 0.0
2025-11-09 2025-11-11 0.0
2025-11-07 2025-11-08 0.0
2025-11-06 2025-11-06 0.0
2025-11-02 2025-11-05 0.0
2025-10-30 2025-11-01 0.0
2025-10-26 2025-10-29 0.0
2025-10-24 2025-10-25 0.0
2025-10-23 2025-10-23 0.0
2025-10-22 2025-10-22 0.0
2025-10-21 2025-10-21 0.0
2025-10-20 2025-10-20 0.0
2025-10-19 2025-10-19 0.0
2025-10-05 2025-10-18 0.0
2025-10-03 2025-10-04 0.0
2025-10-02 2025-10-02 0.0
2025-09-29 2025-10-01 0.0
2025-09-28 2025-09-28 0.0
2025-09-26 2025-09-27 0.0
2025-09-25 2025-09-25 12.05
2025-09-23 2025-09-24 0.0
2025-09-22 2025-09-22 0.0
2025-09-19 2025-09-21 0.0
2025-09-17 2025-09-18 0.0
2025-09-14 2025-09-16 0.0
2025-09-12 2025-09-13 0.0
2025-09-11 2025-09-11 0.0
2025-09-08 2025-09-10 0.0
2025-09-05 2025-09-07 0.0
2025-09-03 2025-09-04 0.0
2025-09-02 2025-09-02 0.0
2025-09-01 2025-09-01 0.0
2025-08-31 2025-08-31 0.0
2025-08-29 2025-08-30 0.0
2025-08-28 2025-08-28 0.0
2025-08-27 2025-08-27 0.0
2025-08-25 2025-08-26 0.0
2025-08-24 2025-08-24 0.0
2025-08-22 2025-08-23 0.0
2025-08-21 2025-08-21 0.0
2025-08-19 2025-08-20 0.0
2025-08-18 2025-08-18 0.0
2025-08-17 2025-08-17 0.0
2025-08-15 2025-08-16 0.0
2025-08-14 2025-08-14 0.0
2025-08-12 2025-08-13 0.0
2025-08-11 2025-08-11 0.0
2025-08-10 2025-08-10 0.0
2025-08-08 2025-08-09 0.0
2025-08-07 2025-08-07 0.0
2025-08-06 2025-08-06 0.0
2025-08-05 2025-08-05 0.0
2025-08-04 2025-08-04 0.0
2025-08-03 2025-08-03 0.0
2025-08-01 2025-08-02 0.0
2025-07-30 2025-07-31 0.0
2025-07-29 2025-07-29 0.0
2025-07-28 2025-07-28 0.0
2025-07-27 2025-07-27 0.0
2025-07-25 2025-07-26 0.0
2025-07-24 2025-07-24 4.32
2025-07-23 2025-07-23 4.32
2025-07-22 2025-07-22 4.32
2025-07-21 2025-07-21 4.32
2025-07-20 2025-07-20 4.32
2025-07-18 2025-07-19 4.32
2025-07-17 2025-07-17 4.32
2025-07-16 2025-07-16 4.32
2025-07-14 2025-07-15 4.32
2025-07-13 2025-07-13 4.32
2025-07-11 2025-07-12 4.32
2025-07-10 2025-07-10 4.32
2025-07-09 2025-07-09 4.32
2025-07-08 2025-07-08 4.32
2025-07-07 2025-07-07 4.32
2025-07-06 2025-07-06 4.32
2025-07-04 2025-07-05 4.32
2025-07-03 2025-07-03 10.8
2025-07-02 2025-07-02 10.8
2025-07-01 2025-07-01 4108.06
2025-06-30 2025-06-30 4102.66
2025-06-28 2025-06-29 4102.66
2025-06-27 2025-06-27 106.34
2025-06-26 2025-06-26 106.34
2025-06-25 2025-06-25 106.34
2025-06-19 2025-06-24 6945.66
2025-06-18 2025-06-18 4701.81
2025-06-17 2025-06-17 4240.49
2025-04-28 2025-04-28 3444.85
2024-10-03 2024-10-09 91.4

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Viva Medical, UAB (code 302820861) is a Private Limited Liability Company operating in wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €895.1K and net profit of €20.1K, corresponding to a profit margin of 2.2%. Revenue declined by 13.0% year on year and was broadly stable over the two-year period, with 2023 revenue at €904.3K, 2024 revenue rising to €1.03M, and 2025 returning below the 2023 level. Profitability improved sharply in 2024, when net profit reached €51.8K, before easing in 2025. The balance sheet strengthened over the period: total assets increased to €283.0K in 2025 from €208.5K in 2024, while equity rose to €141.8K and liabilities to €144.0K. The latest equity ratio was 50.1%, debt-to-equity stood at 1.02, asset turnover at 3.16x, ROE at 14.2%, and ROA at 7.1%. Revenue per employee was €298.4K, with profit per employee of €6.7K.